Valmet and Georgia-Pacific Enter Agreement on eTAD(TM) Technology
Valmet Oyj's trade press release on May 18, 2018 at 11:00 a.m.
Valmet and Georgia-Pacific have entered into a licensing agreement covering the eTAD(TM) tissue making technology. Under the license agreement, Valmet will market, manufacture and install Advantage eTAD machines for tissue customers outside North America.
The eTAD(TM) technology was developed by Georgia-Pacific.The company has three eTAD(TM) machines operating in North America; the latest two re-built by Valmet in 2012. The machines are running in full eTAD(TM) configuration and producing structured tissue and towel with high quality and absorbency. The eTAD(TM) concept provides an ultra-premium product with high bulk to fiber ratio in combination with low energy and water consumption. The concept is also capital efficient.
"We are very excited about this agreement that will support our strategy to provide tissue making solutions that offer top quality tissue with sustainable production. Valmet and its customers will have the possibility to make trial runs on Georgia-Pacific's pilot eTAD(TM) machine, and also bring customers to reference visits at mills with operating eTAD(TM) machines. This agreement will further strengthen our product portfolio and ensure that we are able to provide tissue machine concepts covering the whole product range," says Jan Erikson, VP Sales, Tissue Mills Business Unit, Valmet.
"This technology meets consumer needs for premium qualities in tissue products, including softness and absorbency," says Kurt Adams, Vice President, R&D, Georgia-Pacific. "We are pleased to license eTAD(TM) technology to Valmet as we recognize the value-creating potential of offering this technology more broadly."
Based in Atlanta, Georgia-Pacific and its subsidiaries are among the world's leading manufacturers and marketers of bath tissue, paper towels and napkins, tableware, paper-based packaging, office papers, cellulose, specialty fibers, nonwoven fabrics, building products and related chemicals. The company operates nearly 200 facilities and employs approximately 35,000 people directly, and creates nearly 92,000 jobs indirectly.
For more information please contact:
Jan Erikson, VP Sales, Tissue Mills Business Unit, Valmet tel. +46 705 17 14 90
Anna Umphress, Senior Director, Communications, Georgia-Pacific, tel. +1-404-652-4627
Valmet is the leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. We aim to become the global champion in serving our customers.
Valmet's strong technology offering includes pulp mills, tissue, board and paper production lines, as well as power plants for bioenergy production. Our advanced services and automation solutions improve the reliability and performance of our customers' processes and enhance the effective utilization of raw materials and energy.
Valmet's net sales in 2017 were approximately EUR 3.1 billion. Our more than 12,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward - every day. Valmet's head office is in Espoo, Finland and its shares are listed on the Nasdaq Helsinki.